Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jingnan Liao, Huan Chen, Mingming Qi, Jinjin Wang & Mingyuan Wang. (2022) MLLT11-TRIL complex promotes the progression of endometrial cancer through PI3K/AKT/mTOR signaling pathway. Cancer Biology & Therapy 23:1, pages 211-224.
Read now
Read now
Articles from other publishers (5)
Yang Chen, Yajie Cao, Song Wu, Xu Cao, Ting Cai & Hai Hu. (2023)
Antigen processing and presentation‐related signature‐derived BNIP3 is a novel oncogene and immunotherapy determinant in osteosarcoma based on machine learning and
in vitro
validation
. The Journal of Gene Medicine 26:1.
Crossref
Crossref
Feng Liu, Wen Li, Zhihui Jin & Jia Ye. (2023) METTL3-mediated m6A modification of circRNF220 modulates miR-330-5p/survivin axis to promote osteosarcoma progression. Journal of Cancer Research and Clinical Oncology 149:19, pages 17347-17360.
Crossref
Crossref
Shuming Wang, Weiqin Wu & Xiang Han. (2022) Enhanced MCM5 Level Predicts Bad Prognosis in Acute Myeloid Leukemia. Molecular Biotechnology 65:8, pages 1242-1252.
Crossref
Crossref
Zi Li, Lei Zheng, Liang Yang, Dong Chen, Guohai Ren, Xiongwei Yan & Jian Pu. (2023) Hsa_circ_0020378 targets miR-556-5p/MAPK1 to regulate osteosarcoma cell proliferation and migration. Gene 856, pages 147135.
Crossref
Crossref
Deliang Huang & Dejing Huang. (2022) Relationship between M6A methylation regulator and prognosis in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization. Heliyon 8:10, pages e10931.
Crossref
Crossref